Capsaicin may have important potential for promoting vascular and metabolic health.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing preclinical mechanisms and selected clinical findings without systematic review methodology.
PubMed 26113985 · doi:10.1136/openhrt-2015-000262
What was done
Narrative review of preclinical and clinical evidence regarding the effects of capsaicin and its analogue capsiate on vascular and metabolic health via TRPV1 receptor activation.
What was found
The abstract provides no numerical data or effect sizes. Preclinical findings indicate that TRPV1 activation enhances calcium influx, upregulates eNOS and antioxidant enzymes, stimulates brown adipose tissue thermogenesis, and improves endothelial vasodilation and lipid handling. In clinical contexts, capsaicin or capsiate ingestion modestly increased metabolic rate, and topical capsaicin patches increased exercise time to ischemic threshold in angina patients.
Why it matters
This review synthesizes the mechanistic rationale for exploring capsaicin as an intervention for metabolic and cardiovascular conditions.
Limits
The review relies primarily on preclinical rodent and in vitro models rather than clinical trial data. No sample sizes, meta-analytic pooling, or quantitative outcomes are provided in the abstract, and tolerable human therapeutic dosing protocols are not yet established.
Cited by
- supports Spicy foods induce vasodilation by stimulating nitric oxide production.